Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The systemic tension between the high upfront costs and long-term benefits of GLP-1s is pushing the healthcare system toward a tipping point, exposing its unsustainable cost structure
Exome-wide association study of treatment-resistant depression suggests novel treatment targets
This is the most provocative question in the current GLP-1 research landscape, and it has direct implications for anyone wondering about drinking on tirzepatide
Dandamudi, A., Akbar, H., Cancelas, J
US$ 23.48
US$ 27.67
US$ 26.85
US$ 28.27
US$ 20.76
US$ 21.55
US$ 23.04
US$ 28.50
